Coya Therapeutics operates within the healthcare and biotechnology sector, specializing in clinical-stage biopharmaceutical research. Its core scientific focus centers on developing novel immunotherapies designed to enhance regulatory T cell (Treg) function, targeting neurodegenerative, autoimmune, and chronic inflammatory diseases.